Unbiased and efficient estimation of causal treatment effects in crossover trials
From MaRDI portal
Publication:6595087
DOI10.1002/BIMJ.202200170zbMATH Open1544.62341MaRDI QIDQ6595087FDOQ6595087
Authors: Jeppe Ekstrand Halkjær Madsen, Thomas H. Scheike, C. B. Pipper
Publication date: 29 August 2024
Published in: Biometrical Journal (Search for Journal in Brave)
Cites Work
- Semiparametric theory and missing data.
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
- Simultaneous inference in general parametric models
- Linear and generalized linear mixed models and their applications.
- Elements of causal inference. Foundations and learning algorithms
- Ethical considerations concerning treatment allocation in drug development trials
- Some Surprising Results about Covariate Adjustment in Logistic Regression Models
- Bioequivalence and statistics in clinical pharmacology.
- The use of baseline covariates in crossover studies
- Model-Robust Inference for Clinical Trials that Improve Precision by Stratified Randomization and Covariate Adjustment
- A versatile method for confirmatory evaluation of the effects of a covariate in multiple models
- Small-Sample Methods for Cluster-Robust Variance Estimation and Hypothesis Testing in Fixed Effects Models
This page was built for publication: Unbiased and efficient estimation of causal treatment effects in crossover trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6595087)